Page 210 - Aet News Today

Though hospitals’ financial circumstances were dire this year, some multibillion dollar expansion projects have managed to move forward — including a the construction of a new $5 billion medical campus in Nevada and a new $4.3 billion hospital in San Francisco.

About 51% of U.S. adults are in favor of the Covid-19 public health emergency still in effect, while 39% said it is no longer needed, a recent Morning Consult survey found. Americans’ opinions varied based on political party, generation, race/ethnicity and location.

Many pharma and medical device companies will look inward, with the goal of standardizing and modernizing even highly regulated activities. Here’s a closer look at some important industry trends for 2023.

Hospitals go to great lengths to deliver exceptional care to their patients. That commitment should extend to the digital space. By making your inventory visible, breaking down data silos, and building a better patient experience, providers will have happier patients and healthier margins.

As we collectively address this rising tide of behavioral health needs, we will need more payment reform, more innovation, and continued migration to more prospective payment models and treatment approaches that bring all stakeholders together to care for patients in a holistic manner.

Today, what’s required is an all-in-one, administration-specific data management platform (DMP). Purpose-built, integrated and fully connected across operations, these platforms can automate and facilitate compliance, licensing, credentialing, enrollment and more.

Carallel, a startup that provides digital tools to support family caregivers, recently raised $8.2 million in Series A funding. The Chicago-based company's services are offered as a benefit by health plans and employers.

Nearly a quarter of private sector employees don’t have any paid sick days, according to the National Partnership for Women & Families. Providing this benefit will save employers down the line, one expert argues.

The industry needs to more clearly define the different competencies and career paths within clinical research so all employees can lean into their strengths and build a career plan that brings them fulfillment.

Putting data into the hands of participants is an important step in changing the traditional clinical trial paradigm. It fits in amongst the goal of running nimble and patient-centered studies. But, without legislation, it’s doubtful that pharma companies will give up ownership of participant data out of sheer goodwill.